The S162 mutation is located late in the CrebB open reading frame, truncating about 60 amino acids from any protein isoform that contains the C-terminal bZIP domain.
There is a significant decrease in synaptic bouton numbers at larval neuromuscular junctions (NMJs), compared with wild-type, in CrebB-17AS162 mutants.
Heterozygous CrebB-17AS162 larvae have normal NMJs.
Homozygous CrebB-17AS162 mutants are lethal.
A single copy of CrebB-17AS162 does not cause any lethality.
Mutant flies show a significant increase in the number of rest hours per 24 hours compared to controls.
Mutant flies show significantly increased and prolonged rest rebound after rest deprivation compared to controls.
CrebB-17AS162, though lethal, is not completely penetrant, less than 0.5% of flies survive to adulthood. These escapers are about three quarters the size of wild type flies, but otherwise normal in appearance. Of 34 mutant flies tested for circadian locomotor activity, 13 (38%) were arrhythmic and the rest showed a short period averaging 22.8 hours.
Germline clones demonstrate no maternal effect. Zygotic lethality acts in the third larval instar stage.
CrebBS162/CrebB-17A[+] is an enhancer of partially lethal - majority die phenotype of Hsap\HTTQ48.ex1p.UAS, Scer\GAL4elav-C155
CrebBS162, Df(1)Exel9051/+ has abnormal neuroanatomy | third instar larval stage phenotype
CrebBS162/CrebB[+], Hsap\HTTQ22.ex1p.UAS, Scer\GAL4elav-C155 has viable phenotype
CrebBS162, Hsap\HTTQ48.ex1p.UAS, Scer\GAL4elav-C155 has lethal phenotype
CrebBS162, Scer\GAL430A is a non-enhancer of wing phenotype of Pka-C1UAS.cKa, Scer\GAL430A
CrebBS162 is a suppressor of eye phenotype of CrtcUAS.cWa, Scer\GAL4GMR.PF
CrebBS162, Scer\GAL430A is a non-suppressor of wing phenotype of Pka-C1UAS.cKa, Scer\GAL430A
Heterozygosity for both CrebB-17AS162 and Df(1)Exel9051 results in a significant reduction in neuromuscular junction (NMJ) growth.
A CrebB-17AS162 background suppresses the rough eye phenotype found in TORCScer\UAS.cWa-expressing (under the control of Scer\GAL4GMR.PF) flies.
The survival rate of flies expressing Hsap\HDQ48.ex1p.Scer\UAS in the nervous system (under the regulation of Scer\GAL4elav-C155) is sensitive to the gene dosage of CrebB-17AS162 flies. A CrebB-17AS162 heterozygous background more than doubles the lethality of Hsap\HDQ48.ex1p.Scer\UAS flies compared to flies expressing Hsap\HDQ48.ex1p.Scer\UAS alone (under the control of Scer\GAL4elav-C155).
Addition of a heterozygous CrebB-17AS162 background to CrebB-17A+tIa Hsap\HDQ48.ex1p.Scer\UAS (Scer\GAL4elav-C155) flies reduces the survival rate slightly, although lethality is not as high as in Hsap\HDQ48.ex1p.Scer\UAS (Scer\GAL4elav-C155) flies.
The survival rate of flies expressing Hsap\HDQ22.ex1p.Scer\UAS in the nervous system (under the regulation of Scer\GAL4elav-C155) is not sensitive to the gene dosage of CrebB-17AS162 flies.
Homozygous CrebB-17AS162 flies expressing Hsap\HDQ48.ex1p.Scer\UAS under the control of Scer\GAL4elav-C155 are lethal. Addition of the CrebB-17A+t.STOP transgene to homozygous CrebB-17AS162 flies expressing Hsap\HDQ48.ex1p.Scer\UAS under the control of Scer\GAL4elav-C155 results in an approximate 1% survival rate.
CrebBS162 is not rescued by CrebB+t.STOP